عربي English
HomeAbout UsMembersStatisticsPublicationsNewsEventsGalleryContact UsMembers Area
ADI 5098.115 (AED)  0.74% | AMGNRLX 1980.49 (JOD)  -0.17% | BAX 1160.94 (BHD)  1.35% | BLSI 1207.903 (USD)  0.06% | MASI 10564.6172 (MAD)  -0.15% | DFMGI 3274.06 (AED)  -0.15% | EGX30 10688.16 (EGP)  4.52% | ISX 72.01 (IQD)  0% | KWSE 5275.04 (KWD)  -0.18% | MSI 6317.66 (OMR)  -0.55% | PLE 483.41 (JOD)  -0.01% | QE 12282.17 (QAR)  -0.42% | TASI 9717.9 (SAR)  -0.65% | TUNINDEX 5585.19 (TND)  0.45% | SPAFEUP 64.11 (USD)  -0.02%
Source: Thomson Reuters.   Last updated on Feb 23, 2019 at 02:10AM (UTC).   Delayed by at least 15 minutes.
Beit Jala Pharmaceuticals a Listed Company at Palestine Exchange
Jul 05, 2015
The listing agreement was signed on June 16th 2015 in a ceremony convened at Beit Jala Company premises attended by shareholders, investors, brokerage firms and PCMA representatives. The company's started trading using the Symbol (BJP).

The new listing will raise the listed companies at PEX to 49 with a market capitalization of over USD 3.10 billion.

Beit Jala Pharmaceuticals Company was established in the fifties of last century and transformed into a public shareholding company in 2013, with products distributed locally and a broad Palestine. 


Listing-of-Beit-Jala-Pharmaceuticals.jpg